Connexin expression and cell coupling fail to reverse the v-src transformed growth characteristics of a Cx43-/- cell line

被引:2
作者
Chandrasekhar, A
Merritt, M
Huh, SJ
Nicholson, BJ
Zucker, SN [1 ]
机构
[1] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78284 USA
关键词
connexins; gap junctions; transformation; v-src;
D O I
10.1080/15419060490958757
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gap junctions, composed of connexins, have been shown to suppress transformation in a variety of malignancies and transformed cell types. In addition, transforming factors such as the src oncogene have been shown to directly phosphorylate some connexins (e.g., Cx43) and inhibit coupling. To investigate the role of gap junctions in cell transformsation by v-src, we utilized a clonal cell line derived from Cx43 knockout mice (KoA) that was immortalized, but not transformed. Transfection by v-src induced a marked transformed phenotype characterized by growth in low serum and anchorage-independent conditions. Subsequent transfections by Cx43, Cx32 or vector alone were then tested for their effects on growth. Activity of pp60(v-src) was confirmed in all transfectants as well as the ability of pp60(v-src) to phosphorylate Cx43 in several clones. Despite the documented effect of pp60(v-src) on Cx43 channel closure, modest coupling was still retained in many of the Cx43 and Cx32 transfectants. However, none of the four Cx43 transfected clones showed significant inhibitory effects on proliferation in either anchorage-independent or low serum growth conditions. Of the Cx32 clones, only one in five showed effects on growth in both assays, which was the same ratio observed for the control transfectants. Thus, based on the levels of expression achieved, which were comparable to endogenous levels in established cell lines, neither Cx43 nor Cx32 serve as effective suppressors of the transformed growth phenotype of this v-src expressing cell line.
引用
收藏
页码:103 / 119
页数:17
相关论文
共 43 条
  • [1] Enhanced tumorigenicity of rat bladder squamous cell carcinoma cells after abrogation of gap junctional intercellular communication
    Asamoto, M
    Toriyama-Baba, H
    Krutovskikh, V
    Cohen, SM
    Tsuda, H
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1998, 89 (05): : 481 - 486
  • [2] INCREASED GAP JUNCTIONAL INTERCELLULAR COMMUNICATION CAPACITY AND CONNEXIN 43 AND 26 EXPRESSION IN RAT BLADDER CARCINOGENESIS
    ASAMOTO, M
    TAKAHASHI, S
    IMAIDA, K
    SHIRAI, T
    FUKUSHIMA, S
    [J]. CARCINOGENESIS, 1994, 15 (10) : 2163 - 2166
  • [3] RAPID AND REVERSIBLE REDUCTION OF JUNCTIONAL PERMEABILITY IN CELLS INFECTED WITH A TEMPERATURE-SENSITIVE MUTANT OF AVIAN-SARCOMA VIRUS
    ATKINSON, MM
    MENKO, AS
    JOHNSON, RG
    SHEPPARD, JR
    SHERIDAN, JD
    [J]. JOURNAL OF CELL BIOLOGY, 1981, 91 (02) : 573 - 578
  • [4] Frequent reduction of gap junctional intercellular communication and connexin43 expression in human and mouse lung carcinoma cells
    Cesen-Cummings, K
    Fernstrom, MJ
    Malkinson, AM
    Ruch, RJ
    [J]. CARCINOGENESIS, 1998, 19 (01) : 61 - 67
  • [5] POTENTIAL ROLE OF THE SRC GENE-PRODUCT IN INHIBITION OF GAP-JUNCTIONAL COMMUNICATION IN NIH/3T3 CELLS
    CHANG, CC
    TROSKO, JE
    KUNG, HJ
    BOMBICK, D
    MATSUMURA, F
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (16) : 5360 - 5364
  • [6] The carboxy-tail of connexin-43 localizes to the nucleus and inhibits cell growth
    Dang, XT
    Doble, BW
    Kardami, E
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2003, 242 (1-2) : 35 - 38
  • [7] INVOLVEMENT OF GAP-JUNCTIONS IN TUMORIGENESIS - TRANSFECTION OF TUMOR-CELLS WITH CONNEXIN-32 CDNA RETARDS GROWTH-INVIVO
    EGHBALI, B
    KESSLER, JA
    REID, LM
    ROY, C
    SPRAY, DC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) : 10701 - 10705
  • [8] Gap junction expression following UVC-induced neoplastic transformation in human hybrid cell lines
    Ehring, GR
    Antoniono, RJ
    Redpath, JL
    [J]. CARCINOGENESIS, 1998, 19 (12) : 2085 - 2093
  • [9] FRIEDMAN EA, 1982, CANCER RES, V42, P5096
  • [10] Fukazawa H, 1996, INT J CANCER, V67, P876, DOI 10.1002/(SICI)1097-0215(19960917)67:6<876::AID-IJC19>3.0.CO